
Mediculus Pharma Private Limited
About Mediculus Pharma Private Limited
Data last updated:
Mediculus Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 24 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC279482. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Varsha Pandey and Shanti Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1309 Pragati Tower 26 Rajendra Place, New Delhi, Delhi, India – 110008.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mediculus Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1309 Pragati Tower 26 Rajendra Place, New Delhi, Delhi, India – 110008
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Mediculus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mediculus Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mediculus Pharma Private Limited, buy the company report.
Financials of Mediculus Pharma Private Limited
FY 2025 filings availableMediculus Pharma Private Limited reported revenue of ₹77 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 89% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediculus Pharma Private Limited, buy the company report.
Board of directors of Mediculus Pharma Private Limited
Mediculus Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varsha Pandey | Director | 24 Apr 2015 | 11 Years 6 Months | Current |
| Shanti Pandey | Director | 05 Aug 2020 | 6 Years 3 Months | Current |
Peer comparison
Mediculus Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sensonics Devices Private Limited | ₹100 (FY 2024) | Bangalore, Karnataka, India | ||||
| Leonor Bio Pharma Private Limited | ₹95 (FY 2020) | Hyderabad, Telangana, India | ||||
| Cybersavvy India Private Limited | ₹89 (FY 2024) | -100.0% | Ghaziabad, Uttar Pradesh, India | |||
| Propoke Biotechnologies Private Limited | ₹88 (FY 2018) | Tezpur, Assam, India | ||||
| Corncord Medicals Private Limited | ₹87 (FY 2022) | Chavakkad, Kerala, India | ||||
| Mediculus Pharma Private Limitedthis company | ₹77 (FY 2024) | -100.0% | New Delhi, Delhi, India | |||
| Lakemedel Pharmaceuticals Private Limited | ₹72 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Fuscient Labs Private Limited | ₹63 (FY 2023) | Bangalore, Karnataka, India | ||||
| Kautilya Laboratories Private Limited | ₹59 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Bhagya Health Care Products Private Limited | ₹57 (FY 2018) | -100.0% | Navi Mumbai, Maharashtra, India | |||
| Sereno Life Sciences Private Limited | ₹41 (FY 2025) | -100.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mediculus Pharma Private Limited, buy the company report.
Auditor
Mediculus Pharma Private Limited is audited by Singh Chhabra & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Singh Chhabra & Co | FY 2017 | 012127C |
Shareholding
The shareholding of Mediculus Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mediculus Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mediculus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediculus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediculus Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mediculus Pharma Private Limited, buy the company report.
Recent activity
Mediculus Pharma Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Shanti Pandey ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Mediculus Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 24 April 2015 (11+ years old) and is registered under CIN U24100DL2015PTC279482.
Mediculus Pharma has 2 current directors:
- Varsha Pandey - Director
- Shanti Pandey - Director
The latest financial statements of Mediculus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
No. Mediculus Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mediculus Pharma is U24100DL2015PTC279482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediculus Pharma was incorporated on 24 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mediculus Pharma by revenue are Sensonics Devices Private Limited, Leonor Bio Pharma Private Limited, Cybersavvy India Private Limited, Propoke Biotechnologies Private Limited, Corncord Medicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shanti Pandey ceased to be Additional Director on 30 Dec 2020. Ravindra Kumar Singh ceased to be Director on 10 Sep 2020. Shanti Pandey was appointed as Director on 05 Aug 2020. Mediculus Pharma has 6 board changes on record in total.
The registered office of Mediculus Pharma is at 1309 Pragati Tower 26 Rajendra Place, New Delhi, Delhi, India – 110008.
Mediculus Pharma operates in the chemicals industry, in the chemical products segment.
The compliance status of Mediculus Pharma is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.

